Uncomplicated Staphylococcus aureus Bacteremia Treatment Duration and Outcomes at an Academic Medical Center | Zendy

Daniel Taupin | Zendy; Adolf W. Karchmer | Zendy; Roger B. Davis | Zendy; Mary T. LaSalvia | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Uncomplicated Staphylococcus aureus Bacteremia Treatment Duration and Outcomes at an Academic Medical Center

Author(s) -

Daniel Taupin,

Adolf W. Karchmer,

Roger B. Davis,

Mary T. LaSalvia

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa457

Subject(s) - medicine , bacteremia , staphylococcus aureus , immunosuppression , peripherally inserted central catheter , antibiotics , deep vein , methicillin resistant staphylococcus aureus , thrombosis , surgery , intensive care medicine , catheter , microbiology and biotechnology , genetics , bacteria , biology

We compared outcomes and clinical characteristics of uncomplicated Staphylococcus aureus bacteremia planned for a 14-day or >14-day course of intravenous antibiotics. Treatment failure was infrequent in both groups (0% and 5%, respectively). Catheter-associated deep vein thrombosis, immunosuppression, and valvular dysfunction were associated with a longer planned duration of therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research